CVS Health Corp (NYSE:CVS) traded at $65.57 at close of the session on Tuesday, February 18 and made a downward move of -0.39% on its previous day’s price.
CVS Health Corp has a market cap of $82.67 billion and is expected to release its quarterly earnings report in March. With its Forward Dividend at 2.66 and a yield of 4.06%, the company’s investors could be anxious for the CVS stock to gain ahead of the earnings release.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 93.06B, with a low of 91.26B and a high of 96.05B. The median projection represents growth squeezing down to 5.23% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 387.8B, or 4.02% up from figures reported last year.
On the other hand, looking at the outlook for the CVS stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 50% Sell.
Based on estimates by 20 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 6 have rated the CVS Health Corp (CVS) stock as a Hold, while 14 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note that the PEG ratio for the CVS stock currently stands at 1.30, and the current price level is 14.56% off its SMA20 and 25.95% from its 50-day simple moving average. The RSI (14) is pointing at 77.78 while the volatility over the past week is 4.25% and jumps to 3.04% over the past one month. The beta value is 0.56, while the average true range (ATR) is currently pointing at 2.19. The average price target for the stock over the next 12 months is $69, with the estimates having a low of $66 and a high of $82. These price ends are -0.66% and -25.06% off the current price level respectively, although investors could be excited at the prospect of a -5.23% if the CVS share price touches on the median price of $69.
